Rapid determination of nitazoxanide in tablets using reversed-phase ultra-performance liquid chromatography (UPLC) and high-performance liquid chromatography

Pharmazie

Volumn 63, Issue 7, 2008, Pages 503-507

  Sakamoto, T ^a   Hiyama, Y ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; NIFUROXAZIDE; NITAZOXANIDE; PHOSPHATE;

ARTICLE; CORRELATION COEFFICIENT; DRUG DETERMINATION; DRUG QUALITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TABLET;

ALGORITHMS; ANTIPROTOZOAL AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; PHARMACEUTICAL SOLUTIONS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; TABLETS; THIAZOLES;

EID: 48249145303     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8037     Document Type: Article

References (27)

1. Agarwal A, Ningthouja S, Sharma D, Mohen Y, Singh NB (1998) Cryptosporidium and HIV. J Indian Med Assoc 96: 276-277.
2. Al-Dirbashi OY, Aboul-Enein HY, Jacob M, Al-Qahtani K, Rashed MS (2006) UPLC-MS/MS determination of doxazosine in human plasma. Anal Bioanal Chem 385: 1439-1443.
3. Anand L, Brajachand NG, Dhanachand CH (1996) Cryptosporidiosis in HIV infection. J Commun Dis 28: 241-244.
4. Ananthasubramanian M, Ananthan S, Vennila R, Bhanu S (1997) Cryptosporidium in AIDS patients in south India: a laboratory investigation. J Commun Dis 29: 29-33.
5. Antwerp JV, DePinto R, Jansen D (2005) Meeting analytical challenges with UPLC/MS. Waters Application Note 720001175EN.
6. Apollonio LG, Pianca DJ, Whittall IR, Maher WA, Kyd JK (2006) A demonstration of the use of ultra-performance liquid chromatography-mass spectrometry [UPLC/MS] in the determination of amphetamine-type substances and ketamine for forensic and toxicological analysis. J Chromatogr B Analyt Technol Biomed Life Sci 836: 111-115.
7. Ballal M, Prabhu T, Chandran A, Shivananda PG (1999) Cryptosporidium and isopora belli diarrhoea in immunocompromised hosts. Indian J Cancer 36: 38-42.
8. Benvenuti ME (2005) The science of ACQUITY UPLC applied to environmental analysis of PAHs and explosives in water. Waters Application Note 720001398EN.
9. Brandonisio O, Maggi P, Panaro MA, Bramante LA, DiCoste A, Angarano G (1993) Prevalence of cryptosporidiosis in HIV-infected patients with diarrhoeal illness. Eur J Epidemiol 9: 190-194.
10. Casemore D, Wright S, Coop R (1997) Cryptosporidiosis-human and animal epidemiology, In R. Fayer (ed.), Cryptosporidium and Cryptosporidiosis, CRC press, Boca Raton, Fla 65.
11. Current WL (1983) Human cryptosporidiosis. N Engl J Med 309: 1325-1327.
12. Dubreuil L, Houcke I, Moution Y, Rossignol JF (1996) In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organism. Antimicrob Agents Chemother 40: 2266-2270.
13. Fayer R, Speer C, Dubey J (1997) General biology of Cryptosporidium, In R. Fayer (ed.), Cryptosporidium and Cryptosporidiosis. CRC press, Boca Raton, Fla 1.
14. Jadhav AS, Pathare DB, Shingare MS (2007) A validated stability indicating RP-LC method for nitazoxanide, a new antiparasitic compound. Chromatographia 66: 595-600.
15. Leandro CC, Hancock P, Fussell RJ, Keely BJ (2006) Comparison of ultra-performance liquid chromatography and high-performance liquid chromatography for the determination of priority pesticides in baby foods by tandem quadrupole mass spectrometry. J Chromatogr A 1103: 94-101.
16. Lee PI, Di Gioia AJ (2005) ACQUITY UPLC separation of ink-jet ink dyes. Waters Application Note 720001334EN.
17. Lunn G (2005) HPLC methods for recently approved pharmaceuticals, Wiley-Interscience, John Wiley & Sons, Inc. Publication, NJ.
18. Pedersen C, Danner S, Lazzarin A, Glauser MP, Weber R, Katlama C, Bartom SE, Lundgren JD (1996) Epidemiology of cryptosporidiosis among European AIDS patients. Genitourin Med 72: 128-131.
19. Rainville P, Wilson I, Plumb R, Johnson K (2005) Comparison of 1- and 2-Millimeter ACQUITY UPLC columns for LC/MS. Waters Application Note 720001126EN.
20. Rossignol JF, Maisonneuve H (1984) Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana. Am J Trop Med Hyg 33: 511-512.
21. Ryan C, Kearney G (2005) New technologies for the simultaneous analysis of multiple pesticide residues in agricultural produce. Waters Application Note 720001172EN.
22. Sherma J (2005) A field guide to instrumentation; UPLC: Ultra-performance liquid chromatography. J AOAC Int 88: 63-67.
23. Sorvillo FJ, Lieb LE, Kerndt PR, Ash LR (1994) Epidemiology of cryptosporidiosis among persons with acquired immunodeficiency syndrome in Los Angeles County. Am J Trop Med Hyg 51: 326-331.
24. Stockis A, Deroubaix X, Lins R, Jeanbaptiste B, Calderon P, Rossignol JF (1996) Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers. Int J Clin Pharmacol Therap 34: 349-351.
25. Wang G, Hsieh Y, Cui X, Cheng KC, Korfmacher WA (2006) Ultra-performance liquid chromatography/tandem mass spectrometric determination of testosterone and its metabolites in in vitro samples. Rapid Commun Mass Spectrom 20: 2215-2221.
26. Wren SA, Tchelitcheff P (2006) UPLC/MS for the identification of beta-blockers. J Pharm Biomed Anal 24: 571-580.
27. Yin P, Zhao X, Li Q, Wang J, Li J, Xu G (2006) Metabonomics study of intestinal fistulas based on ultra performance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). J Proteome Res 5: 2135-2143.